OneMedForum Recap: Pressure Biosciences
Pressure Biosciences (PBIO) is a life sciences company centered on developing and commercializing a novel technology titled Pressure Cycling Technology (PCT).
pressure biosciences
Hunting Disease In The Dark: MEDomics Seeks to Treat Mitochondrial Disease Before It Occurs
The core theory behind preventative medicine is almost psychic. To stop a disease from wielding its mighty weapons before it occurs is based on foreknowledge of a patient’s susceptibility to the illness.
OneMedPlace Announces “OneMedForum 2011” Finance Conference for Emerging Healthcare and Life Science Companies
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
Michael Bloomberg Proclaims “OneMedForum Days” in New York City
The OneMedForum was recognized by Michael R. Bloomberg, Mayor of New York City, as an important event supporting innovation in the healthcare and life science industries.
OneMedForum New York 2010 Successfully Brings Together Innovators and Investors
The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
Pressure BioSciences Presents Symposium On Applications of PCT Technology
On May 21, 2010 Pressure BioSciences, Inc. (NasdaqCM: PBIO) sponsored a symposium at Harvard Medical School on the “Applications of Ultra-High Pressure in Technology.”
Pressure BioSciences Aims for Improved Sample Preparation
Pressure BioSciences seeks to improve sample yield with its novel technology platform, known as pressure cycling technology (PCT).
Pressure BioSciences at the 2010 OneMedForum
Richard Schumacher, CEO of Pressure BioSciences, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
OneMedPlace Interviews Richard T. Schumacher, CEO of Pressure Biosciences
Pressure Biosciences CEO Rick Schumacher discusses the company’s proprietary technology and the high-profile clients that are using it.
[Company Profile] Pressure BioSciences
Pressure BioSciences is developing a novel process called Pressure Cycling Technology (PCT) for sample preparation in the study of genomes and proteins.